Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP897932.RAJ2X_zKDhYKj80Z9dTlaHSNzG45aU_yBfFdrzCbVL0_g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP897932.RAJ2X_zKDhYKj80Z9dTlaHSNzG45aU_yBfFdrzCbVL0_g130_assertion type Assertion NP897932.RAJ2X_zKDhYKj80Z9dTlaHSNzG45aU_yBfFdrzCbVL0_g130_head.
- NP897932.RAJ2X_zKDhYKj80Z9dTlaHSNzG45aU_yBfFdrzCbVL0_g130_assertion description "[Therapeutic measures include interferon-alpha for CDA I, splenectomy for CDA II, and iron depletion for all individuals at risk for secondary hemochromatosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP897932.RAJ2X_zKDhYKj80Z9dTlaHSNzG45aU_yBfFdrzCbVL0_g130_provenance.
- NP897932.RAJ2X_zKDhYKj80Z9dTlaHSNzG45aU_yBfFdrzCbVL0_g130_assertion evidence source_evidence_literature NP897932.RAJ2X_zKDhYKj80Z9dTlaHSNzG45aU_yBfFdrzCbVL0_g130_provenance.
- NP897932.RAJ2X_zKDhYKj80Z9dTlaHSNzG45aU_yBfFdrzCbVL0_g130_assertion SIO_000772 15278299 NP897932.RAJ2X_zKDhYKj80Z9dTlaHSNzG45aU_yBfFdrzCbVL0_g130_provenance.
- NP897932.RAJ2X_zKDhYKj80Z9dTlaHSNzG45aU_yBfFdrzCbVL0_g130_assertion wasDerivedFrom befree-20140225 NP897932.RAJ2X_zKDhYKj80Z9dTlaHSNzG45aU_yBfFdrzCbVL0_g130_provenance.
- NP897932.RAJ2X_zKDhYKj80Z9dTlaHSNzG45aU_yBfFdrzCbVL0_g130_assertion wasGeneratedBy ECO_0000203 NP897932.RAJ2X_zKDhYKj80Z9dTlaHSNzG45aU_yBfFdrzCbVL0_g130_provenance.